Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

ClinicalTrials.gov ID: NCT00034294

Public ClinicalTrials.gov record NCT00034294. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Study of GT160-246 Versus Vancomycin in Patients With C. Difficile-Associated Diarrhea

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Approximately 300 patients will be entered into this study taking place throughout the United States, Canada and the United Kingdom. This study aims to determine if an investigational drug is safe and effective for treating the symptoms of C. difficile-associated diarrhea and lowering the risk of repeat episodes of diarrhea. The investigational drug will be evaluated in comparison to current standard antibiotic treatment, so all patients will receive active medication. All study-related care is provided including doctor visits, physical exams, laboratory tests and study medication. Total length of participation is approximately 10 weeks.

Study identification

NCT ID
NCT00034294
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genzyme, a Sanofi Company
Industry
Enrollment
300 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2002 (Type not available)
Primary completion
Not listed
Completion
Jul 2003 (Actual)
Last update posted
Mar 5, 2015

2002 – 2003

United States locations

U.S. sites
58
U.S. states
28
U.S. cities
53
Facility City State ZIP Site status
Not listed Mobile Alabama 36617 —
Not listed Phoenix Arizona 85006 —
Not listed Tucson Arizona 85724 —
Not listed Little Rock Arkansas 72205 —
Not listed Sacramento California 95816 —
Not listed Newark Delaware 19718 —
Not listed Bay Pines Florida 33744 —
Not listed Brandon Florida 33511 —
Not listed Hollywood Florida 33021 —
Not listed Naples Florida 34102 —
Not listed Orlando Florida 32806 —
Not listed Austell Georgia 30106 —
Not listed Columbus Georgia 31902 —
Not listed Chicago Illinois 60611 —
Not listed Maywood Illinois 60153 —
Not listed North Chicago Illinois 60064 —
Not listed Columbus Indiana 47203 —
Not listed Des Moines Iowa 50309 —
Not listed Des Moines Iowa 50314 —
Not listed Wichita Kansas 67214 —
Not listed Lexington Kentucky 40536-0084 —
Not listed Louisville Kentucky 40202 —
Not listed New Orleans Louisiana 70112 —
Not listed Baltimore Maryland 21215 —
Not listed Chevy Chase Maryland 20815 —
Not listed Boston Massachusetts 02111 —
Not listed Braintree Massachusetts 02185 —
Not listed West Roxbury Massachusetts 02132 —
Not listed Springfield Missouri 65807 —
Not listed St Louis Missouri 63110 —
Not listed Stratford New Jersey 08084 —
Not listed Buffalo New York 14215 —
Not listed Jamaica New York 11432 —
Not listed Manhasset New York 11030 —
Not listed New York New York 10010 —
Not listed New York New York 10032 —
Not listed Syracuse New York 13210 —
Not listed Asheville North Carolina 28801 —
Not listed Charlotte North Carolina 28203 —
Not listed Fargo North Dakota 58122 —
Not listed Columbus Ohio 43215 —
Not listed Toledo Ohio 43608 —
Not listed Oklahoma City Oklahoma 73104 —
Not listed Allentown Pennsylvania 18105 —
Not listed Hershey Pennsylvania 17033 —
Not listed Philadelphia Pennsylvania 19102 —
Not listed Philadelphia Pennsylvania 19129 —
Not listed Philadelphia Pennsylvania 19140 —
Not listed Pittsburgh Pennsylvania 15261 —
Not listed Upland Pennsylvania 19013 —
Not listed Charleston South Carolina 29425 —
Not listed Clarksville Tennessee 37043 —
Not listed Memphis Tennessee 38104 —
Not listed Temple Texas 76508 —
Not listed Falls Church Virginia 22042 —
Not listed Richmond Virginia 23249 —
Not listed Richmond Virginia 23294 —
Not listed Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00034294, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2015 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00034294 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →